Ehrlichia canis DIVA (differentiate infected from vaccinated animals)

Details for Australian Patent Application No. 2006231473 (hide)

Owner IDEXX Laboratories, Inc.

Inventors Beall, Melissa; Krah, Eugene Regis III

Agent Spruson & Ferguson

Pub. Number AU-B-2006231473

PCT Pub. Number WO2006/107924

Priority 60/668,205 04.04.05 US

Filing date 4 April 2006

Wipo publication date 12 October 2006

Acceptance publication date 12 January 2012

International Classifications

C07K 14/29 (2006.01) Peptides having more than 20 amino acids

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/107924 Priority application(s): WO2006/107924

12 January 2012 Application Accepted

  Published as AU-B-2006231473

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006231484-Hand-held coating dispensing device

2006231470-Lipophilic dye-based FRET assays for Clostridial toxin activity